List of works by Eric D Bateman

24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids

scientific article

Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids

scientific article

Corrigendum to “Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial” [Res Med 108 (2014) 41–49]

article

Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial

article

Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial

article

Efficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trial

scientific article published on October 2013

Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial

scientific article

Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial

scientific article published on 6 October 2011

Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial

scientific article published on 09 August 2011

Fluticasone furoate-vilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trial.

scientific article published on 24 April 2014

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma

scientific article published on 21 December 2011

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

scientific article published on 12 December 2013

Lung function defects in treated pulmonary tuberculosis patients

scientific article published in January 2016

Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone ⬇️

scientific article

Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma

scientific article published on 17 October 2013

Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids

scientific article

Predicting Responders to Reslizumab after 16 Weeks of Treatment Using an Algorithm Derived from Clinical Studies of Severe Eosinophilic Asthma Patients

article

Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial

scientific article published on 6 January 2017

Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial

scientific article published on 25 February 2013

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results

scientific article

Paulina is supported by:

About Paulina

Help